RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:254379

Linear lichen planus

high confidenceDisorder

Also known as: Blaschkoid LP · Blaschkoid lichen planus · Linear LP

Query health: suspect — Only one of 2 strategies returned hits (phrase).

Publications

319

77.8th percentile

Trials

0

Interventional, condition-specific

Researchers

840

Distinct authors in sample

Gene link

—

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

Linear lichen planus (LLP), also referred to as Blaschkoid LP, is a rare type of lichen planus characterized by a linear distribution of lichenoid lesions along the lines of Blaschko, which are embryonic pathways of skin development.

How rare: How common this is has not been clearly measured.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (1)

linear LP

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    319 matched papers (190 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPartial

    None under the specific name; 143 for broader category lichen planus

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

319

319 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

319 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

190 in the last 10 years · high confidence · 77.8th percentile (publications denominator)

Phrase hits: 319 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

840

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Das A4 papers · 2021

    Department of Dermatology, Medical College, Kolkata, West Bengal, India.

    Papers in Europe PMC
  2. 02
    Kumar P3 papers · 2021

    Medical College, Kolkata, India.

    Papers in Europe PMC
  3. 03
    Kumar S3 papers · 2021

    Department of Pathology, Pandit B.D Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.

    Papers in Europe PMC
  4. 04
    Aleissa AI2 papers · 2023

    College of Medicine, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.

    Papers in Europe PMC
  5. 05
    Bandyopadhyay D2 papers · 2015

    Department of Dermatology, Venereology and Leprosy, Medical College and Hospitals, Kolkata, West Bengal, India.

    Papers in Europe PMC
  6. 06
    Barankin B2 papers · 2020

    Toronto Dermatology Centre, Toronto, Ontario M3H 5Y8, Canada.

    Papers in Europe PMC
  7. 07
    Batrani M2 papers · 2023

    Consultant Dermatopathologist, Delhi Dermpath Laboratory, Delhi Dermatology Group, New Delhi, India.

    Papers in Europe PMC
  8. 08
    Bhari N2 papers · 2025

    Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.

    Papers in Europe PMC
  9. 09
    Bochkova MS2 papers · 2026

    Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center, Ural Branch, Russian Academy of Sciences, Perm, Russia.

    Papers in Europe PMC
  10. 10
    Choi JH2 papers · 2012
    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 143 trials are registered for lichen planus, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

high confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

143 interventional trials matched lichen planus, the broader category — listed below. Those studies are not counted in the condition-specific total.

Broader category: lichen planus

143

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Linear lichen planus" OR "Blaschkoid LP" OR "Blaschkoid lichen planus" OR "Linear LP"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Linear lichen planus" OR "Blaschkoid LP" OR "Blaschkoid lichen planus" OR "Linear LP" OR "lichen disease"

Recall-expansion terms: lichen disease

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"lichen planus"

Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T11:02:22.747Z